 | • レポートコード：GIR-23F3937 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、72ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥501,120 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥751,680 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,002,240 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Sorafenib Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界のソラフェニブの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 ソラフェニブ市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・特許医薬品、ジェネリック医薬品 アプリケーション別セグメントは次のように区分されます。 ・腎臓がん、肝臓がん、甲状腺がん、その他 世界のソラフェニブ市場の主要なマーケットプレーヤーは以下のとおりです。 ・Bayer、Natco Pharma、Cipla、Mylan 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - ソラフェニブの概要 - タイプ別分析（2017年vs2021年vs2028年）：特許医薬品、ジェネリック医薬品 - アプリケーション別分析（2017年vs2021年vs2028年）：腎臓がん、肝臓がん、甲状腺がん、その他 - 世界のソラフェニブ市場規模・予測 - 世界のソラフェニブ生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Bayer、Natco Pharma、Cipla、Mylan ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：特許医薬品、ジェネリック医薬品 ・アプリケーション別分析2017年-2028年：腎臓がん、肝臓がん、甲状腺がん、その他 ・ソラフェニブの北米市場分析 - ソラフェニブの北米市場：タイプ別市場規模2017年-2028年 - ソラフェニブの北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・ソラフェニブのヨーロッパ市場分析 - ：ソラフェニブのヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：ソラフェニブのヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・ソラフェニブのアジア太平洋市場分析 - ソラフェニブのアジア太平洋市場：タイプ別市場規模2017年-2028年 - ソラフェニブのアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・ソラフェニブの南米市場分析 - ソラフェニブの南米市場：タイプ別市場規模2017年-2028年 - ソラフェニブの南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・ソラフェニブの中東・アフリカ市場分析 - ソラフェニブの中東・アフリカ市場：タイプ別市場規模2017年-2028年 - ソラフェニブの中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Sorafenib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Sorafenib market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Kidney Cancer accounting for % of the Sorafenib global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Patented Drugs segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Sorafenib include Bayer, Natco Pharma, Cipla, Mylan, and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Sorafenib market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Patented Drugs
Generic Drugs
Market segment by Application can be divided into
Kidney Cancer
Liver Cancer
Thyroid Cancer
Other
The key market players for global Sorafenib market are listed below:
Bayer
Natco Pharma
Cipla
Mylan
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sorafenib product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Sorafenib, with price, sales, revenue and global market share of Sorafenib from 2019 to 2022.
Chapter 3, the Sorafenib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sorafenib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Sorafenib market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Sorafenib.
Chapter 13, 14, and 15, to describe Sorafenib sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Sorafenib Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Sorafenib Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Patented Drugs
1.2.3 Generic Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Sorafenib Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Kidney Cancer
1.3.3 Liver Cancer
1.3.4 Thyroid Cancer
1.3.5 Other
1.4 Global Sorafenib Market Size & Forecast
1.4.1 Global Sorafenib Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Sorafenib Sales in Volume (2017-2028)
1.4.3 Global Sorafenib Price (2017-2028)
1.5 Global Sorafenib Production Capacity Analysis
1.5.1 Global Sorafenib Total Production Capacity (2017-2028)
1.5.2 Global Sorafenib Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Sorafenib Market Drivers
1.6.2 Sorafenib Market Restraints
1.6.3 Sorafenib Trends Analysis
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Sorafenib Product and Services
2.1.4 Bayer Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Natco Pharma
2.2.1 Natco Pharma Details
2.2.2 Natco Pharma Major Business
2.2.3 Natco Pharma Sorafenib Product and Services
2.2.4 Natco Pharma Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Cipla
2.3.1 Cipla Details
2.3.2 Cipla Major Business
2.3.3 Cipla Sorafenib Product and Services
2.3.4 Cipla Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Mylan
2.4.1 Mylan Details
2.4.2 Mylan Major Business
2.4.3 Mylan Sorafenib Product and Services
2.4.4 Mylan Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Sorafenib Breakdown Data by Manufacturer
3.1 Global Sorafenib Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Sorafenib Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Sorafenib
3.4 Market Concentration Rate
3.4.1 Top 3 Sorafenib Manufacturer Market Share in 2021
3.4.2 Top 6 Sorafenib Manufacturer Market Share in 2021
3.5 Global Sorafenib Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Sorafenib Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Sorafenib Market Size by Region
4.1.1 Global Sorafenib Sales in Volume by Region (2017-2028)
4.1.2 Global Sorafenib Revenue by Region (2017-2028)
4.2 North America Sorafenib Revenue (2017-2028)
4.3 Europe Sorafenib Revenue (2017-2028)
4.4 Asia-Pacific Sorafenib Revenue (2017-2028)
4.5 South America Sorafenib Revenue (2017-2028)
4.6 Middle East and Africa Sorafenib Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Sorafenib Sales in Volume by Type (2017-2028)
5.2 Global Sorafenib Revenue by Type (2017-2028)
5.3 Global Sorafenib Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Sorafenib Sales in Volume by Application (2017-2028)
6.2 Global Sorafenib Revenue by Application (2017-2028)
6.3 Global Sorafenib Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Sorafenib Sales by Type (2017-2028)
7.2 North America Sorafenib Sales by Application (2017-2028)
7.3 North America Sorafenib Market Size by Country
7.3.1 North America Sorafenib Sales in Volume by Country (2017-2028)
7.3.2 North America Sorafenib Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Sorafenib Sales by Type (2017-2028)
8.2 Europe Sorafenib Sales by Application (2017-2028)
8.3 Europe Sorafenib Market Size by Country
8.3.1 Europe Sorafenib Sales in Volume by Country (2017-2028)
8.3.2 Europe Sorafenib Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Sorafenib Sales by Type (2017-2028)
9.2 Asia-Pacific Sorafenib Sales by Application (2017-2028)
9.3 Asia-Pacific Sorafenib Market Size by Region
9.3.1 Asia-Pacific Sorafenib Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Sorafenib Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Sorafenib Sales by Type (2017-2028)
10.2 South America Sorafenib Sales by Application (2017-2028)
10.3 South America Sorafenib Market Size by Country
10.3.1 South America Sorafenib Sales in Volume by Country (2017-2028)
10.3.2 South America Sorafenib Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Sorafenib Sales by Type (2017-2028)
11.2 Middle East & Africa Sorafenib Sales by Application (2017-2028)
11.3 Middle East & Africa Sorafenib Market Size by Country
11.3.1 Middle East & Africa Sorafenib Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Sorafenib Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Sorafenib and Key Manufacturers
12.2 Manufacturing Costs Percentage of Sorafenib
12.3 Sorafenib Production Process
12.4 Sorafenib Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Sorafenib Typical Distributors
13.3 Sorafenib Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Sorafenib Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Sorafenib Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer Sorafenib Product and Services
Table 6. Bayer Sorafenib Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Natco Pharma Basic Information, Manufacturing Base and Competitors
Table 8. Natco Pharma Major Business
Table 9. Natco Pharma Sorafenib Product and Services
Table 10. Natco Pharma Sorafenib Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Cipla Basic Information, Manufacturing Base and Competitors
Table 12. Cipla Major Business
Table 13. Cipla Sorafenib Product and Services
Table 14. Cipla Sorafenib Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Mylan Basic Information, Manufacturing Base and Competitors
Table 16. Mylan Major Business
Table 17. Mylan Sorafenib Product and Services
Table 18. Mylan Sorafenib Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Global Sorafenib Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 20. Global Sorafenib Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 21. Market Position of Manufacturers in Sorafenib, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 22. Global Sorafenib Production Capacity by Company, (K Units): 2020 VS 2021
Table 23. Head Office and Sorafenib Production Site of Key Manufacturer
Table 24. Sorafenib New Entrant and Capacity Expansion Plans
Table 25. Sorafenib Mergers & Acquisitions in the Past Five Years
Table 26. Global Sorafenib Sales by Region (2017-2022) & (K Units)
Table 27. Global Sorafenib Sales by Region (2023-2028) & (K Units)
Table 28. Global Sorafenib Revenue by Region (2017-2022) & (USD Million)
Table 29. Global Sorafenib Revenue by Region (2023-2028) & (USD Million)
Table 30. Global Sorafenib Sales by Type (2017-2022) & (K Units)
Table 31. Global Sorafenib Sales by Type (2023-2028) & (K Units)
Table 32. Global Sorafenib Revenue by Type (2017-2022) & (USD Million)
Table 33. Global Sorafenib Revenue by Type (2023-2028) & (USD Million)
Table 34. Global Sorafenib Price by Type (2017-2022) & (USD/Unit)
Table 35. Global Sorafenib Price by Type (2023-2028) & (USD/Unit)
Table 36. Global Sorafenib Sales by Application (2017-2022) & (K Units)
Table 37. Global Sorafenib Sales by Application (2023-2028) & (K Units)
Table 38. Global Sorafenib Revenue by Application (2017-2022) & (USD Million)
Table 39. Global Sorafenib Revenue by Application (2023-2028) & (USD Million)
Table 40. Global Sorafenib Price by Application (2017-2022) & (USD/Unit)
Table 41. Global Sorafenib Price by Application (2023-2028) & (USD/Unit)
Table 42. North America Sorafenib Sales by Country (2017-2022) & (K Units)
Table 43. North America Sorafenib Sales by Country (2023-2028) & (K Units)
Table 44. North America Sorafenib Revenue by Country (2017-2022) & (USD Million)
Table 45. North America Sorafenib Revenue by Country (2023-2028) & (USD Million)
Table 46. North America Sorafenib Sales by Type (2017-2022) & (K Units)
Table 47. North America Sorafenib Sales by Type (2023-2028) & (K Units)
Table 48. North America Sorafenib Sales by Application (2017-2022) & (K Units)
Table 49. North America Sorafenib Sales by Application (2023-2028) & (K Units)
Table 50. Europe Sorafenib Sales by Country (2017-2022) & (K Units)
Table 51. Europe Sorafenib Sales by Country (2023-2028) & (K Units)
Table 52. Europe Sorafenib Revenue by Country (2017-2022) & (USD Million)
Table 53. Europe Sorafenib Revenue by Country (2023-2028) & (USD Million)
Table 54. Europe Sorafenib Sales by Type (2017-2022) & (K Units)
Table 55. Europe Sorafenib Sales by Type (2023-2028) & (K Units)
Table 56. Europe Sorafenib Sales by Application (2017-2022) & (K Units)
Table 57. Europe Sorafenib Sales by Application (2023-2028) & (K Units)
Table 58. Asia-Pacific Sorafenib Sales by Region (2017-2022) & (K Units)
Table 59. Asia-Pacific Sorafenib Sales by Region (2023-2028) & (K Units)
Table 60. Asia-Pacific Sorafenib Revenue by Region (2017-2022) & (USD Million)
Table 61. Asia-Pacific Sorafenib Revenue by Region (2023-2028) & (USD Million)
Table 62. Asia-Pacific Sorafenib Sales by Type (2017-2022) & (K Units)
Table 63. Asia-Pacific Sorafenib Sales by Type (2023-2028) & (K Units)
Table 64. Asia-Pacific Sorafenib Sales by Application (2017-2022) & (K Units)
Table 65. Asia-Pacific Sorafenib Sales by Application (2023-2028) & (K Units)
Table 66. South America Sorafenib Sales by Country (2017-2022) & (K Units)
Table 67. South America Sorafenib Sales by Country (2023-2028) & (K Units)
Table 68. South America Sorafenib Revenue by Country (2017-2022) & (USD Million)
Table 69. South America Sorafenib Revenue by Country (2023-2028) & (USD Million)
Table 70. South America Sorafenib Sales by Type (2017-2022) & (K Units)
Table 71. South America Sorafenib Sales by Type (2023-2028) & (K Units)
Table 72. South America Sorafenib Sales by Application (2017-2022) & (K Units)
Table 73. South America Sorafenib Sales by Application (2023-2028) & (K Units)
Table 74. Middle East & Africa Sorafenib Sales by Region (2017-2022) & (K Units)
Table 75. Middle East & Africa Sorafenib Sales by Region (2023-2028) & (K Units)
Table 76. Middle East & Africa Sorafenib Revenue by Region (2017-2022) & (USD Million)
Table 77. Middle East & Africa Sorafenib Revenue by Region (2023-2028) & (USD Million)
Table 78. Middle East & Africa Sorafenib Sales by Type (2017-2022) & (K Units)
Table 79. Middle East & Africa Sorafenib Sales by Type (2023-2028) & (K Units)
Table 80. Middle East & Africa Sorafenib Sales by Application (2017-2022) & (K Units)
Table 81. Middle East & Africa Sorafenib Sales by Application (2023-2028) & (K Units)
Table 82. Sorafenib Raw Material
Table 83. Key Manufacturers of Sorafenib Raw Materials
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Sorafenib Typical Distributors
Table 87. Sorafenib Typical Customers
List of Figures
Figure 1. Sorafenib Picture
Figure 2. Global Sorafenib Revenue Market Share by Type in 2021
Figure 3. Patented Drugs
Figure 4. Generic Drugs
Figure 5. Global Sorafenib Revenue Market Share by Application in 2021
Figure 6. Kidney Cancer
Figure 7. Liver Cancer
Figure 8. Thyroid Cancer
Figure 9. Other
Figure 10. Global Sorafenib Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Sorafenib Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Sorafenib Sales (2017-2028) & (K Units)
Figure 13. Global Sorafenib Price (2017-2028) & (USD/Unit)
Figure 14. Global Sorafenib Production Capacity (2017-2028) & (K Units)
Figure 15. Global Sorafenib Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Sorafenib Market Drivers
Figure 17. Sorafenib Market Restraints
Figure 18. Sorafenib Market Trends
Figure 19. Global Sorafenib Sales Market Share by Manufacturer in 2021
Figure 20. Global Sorafenib Revenue Market Share by Manufacturer in 2021
Figure 21. Sorafenib Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Sorafenib Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Sorafenib Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Sorafenib Sales Market Share by Region (2017-2028)
Figure 25. Global Sorafenib Revenue Market Share by Region (2017-2028)
Figure 26. North America Sorafenib Revenue (2017-2028) & (USD Million)
Figure 27. Europe Sorafenib Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Sorafenib Revenue (2017-2028) & (USD Million)
Figure 29. South America Sorafenib Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Sorafenib Revenue (2017-2028) & (USD Million)
Figure 31. Global Sorafenib Sales Market Share by Type (2017-2028)
Figure 32. Global Sorafenib Revenue Market Share by Type (2017-2028)
Figure 33. Global Sorafenib Price by Type (2017-2028) & (USD/Unit)
Figure 34. Global Sorafenib Sales Market Share by Application (2017-2028)
Figure 35. Global Sorafenib Revenue Market Share by Application (2017-2028)
Figure 36. Global Sorafenib Price by Application (2017-2028) & (USD/Unit)
Figure 37. North America Sorafenib Sales Market Share by Type (2017-2028)
Figure 38. North America Sorafenib Sales Market Share by Application (2017-2028)
Figure 39. North America Sorafenib Sales Market Share by Country (2017-2028)
Figure 40. North America Sorafenib Revenue Market Share by Country (2017-2028)
Figure 41. United States Sorafenib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Sorafenib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Sorafenib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Sorafenib Sales Market Share by Type (2017-2028)
Figure 45. Europe Sorafenib Sales Market Share by Application (2017-2028)
Figure 46. Europe Sorafenib Sales Market Share by Country (2017-2028)
Figure 47. Europe Sorafenib Revenue Market Share by Country (2017-2028)
Figure 48. Germany Sorafenib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Sorafenib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Sorafenib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Sorafenib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Sorafenib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Sorafenib Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Sorafenib Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Sorafenib Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Sorafenib Revenue Market Share by Region (2017-2028)
Figure 57. China Sorafenib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Sorafenib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Sorafenib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Sorafenib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Sorafenib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Sorafenib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Sorafenib Sales Market Share by Type (2017-2028)
Figure 64. South America Sorafenib Sales Market Share by Application (2017-2028)
Figure 65. South America Sorafenib Sales Market Share by Country (2017-2028)
Figure 66. South America Sorafenib Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Sorafenib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Sorafenib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Sorafenib Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Sorafenib Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Sorafenib Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Sorafenib Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Sorafenib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Sorafenib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Sorafenib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Sorafenib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Sorafenib in 2021
Figure 78. Manufacturing Process Analysis of Sorafenib
Figure 79. Sorafenib Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
• 日本語訳：ソラフェニブのグローバル市場2022年
• レポートコード：GIR-23F3937 ▷ お問い合わせ（見積依頼・ご注文・質問）